Loading

Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/signaling.2.030

Commentary to: Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response

  • 1The University of Texas M.D. Anderson Cancer Center, USA
+ Affiliations - Affiliations

Corresponding Author

 Gabriel Lopez-Berestein, glopez@mdanderson.org

Received Date: January 24, 2024

Accepted Date: February 28, 2024

Keywords

sepsis, immune response, miR-93-5p, S-S.M.A.R.T., checkpoint inhibitors

Author Information X